Page URL:
CONTENTS Issue #642
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

With an eye to the future - preliminary results of clinical trial in human embryonic stem cell-based therapy of macular degeneration
31 January 2012 - by Dr Dusko Ilic and Dr Emma Stephenson
Last week, Advanced Cell Technology (ACT) of Massachusetts, USA, made two important announcements regarding human embryonic stem (hES) cell-based therapies for the potential treatment of Stargardt's dystrophy and age-related macular degeneration, two devastating degenerative disease leading to blindness.... [Read More]
Crystal ball gazing: human embryonic stem cells in 2012
31 January 2012 - by Dr Dusko Ilic
In the last few months of 2011, a couple of stories on human embryonic stem cells hit the headlines. Both were bad news for stem cell researchers... [Read More]
Artificial testicle research given go-ahead
31 January 2012 - by Dr Sophie Pryor
The development of world's first artificial testicle for production of human sperm has been given the go ahead... [Read More]
Chromosome analysis increases IVF success
31 January 2012 - by Ayesha Jadoon
A new method of looking for chromosomal abnormalities in embryos can increase the chance of successful IVF implantation, a recent study in the journal Fertilisation In Vitro has shown.... [Read More]
Cancer drugs may boost breast cancer stem cell growth
31 January 2012 - by Dr Maria Botcharova
Two breast cancer drugs, Avastin and Sutent, may inadvertently aid cancer growth, a study in mice suggests. The drugs, designed to reduce the blood supply to tumours, were found to encourage cancer stem cell growth, potentially fuelling the spread of the cancer... [Read More]
Stem cell transplants hold hope for treating blindness
31 January 2012 - by Rosemary Paxman
A clinical trial testing the safety of using human embryonic stem cell (hESC) in the treatment of progressive eye conditions has been carried out by researchers in the USA... [Read More]
Roche attempts $5.7bn takeover of DNA sequencing firm Illumina
31 January 2012 - by Ruth Saunders
Swiss pharmaceutical company Roche has made an unsolicited bid worth $5.7 billion to takeover US DNA sequencing firm Illumina.... [Read More]
Report examines genomic medicine on the NHS
31 January 2012 - by Dr Linda Wijlaars
Genomic medicine will be at the forefront of the NHS, according to a report released last week by the Human Genomics Strategy Group (HGSG). The report highlights the UK's achievements in genomic technology to date and makes six recommendations to ensure future benefit of genomic innovation within the NHS... [Read More]
Genetic regions linked to timing of menopause
31 January 2012 - by Victoria Kay
Thirteen genomic regions appear to influence the age at onset of menopause, according to a genetic study. These regions contain genes involved in DNA repair and immune responses, processes not previously linked to menopause... [Read More]
Early life factors may impact genes of Glasgow's poorest, study claims
31 January 2012 - by Dr Lux Fatimathas
Unhealthy lifestyles associated with social deprivation may have detrimental effects on DNA before birth, say scientists. A study of adults living in Glasgow shows a correlation between deprivation and DNA methylation - a normal process that occurs mainly during embryonic development and regulates gene activity... [Read More]
Event Review: European Union Ban on Human Embryonic Stem Cell Patents - A Threat to Science and the Rule of Law
31 January 2012 - by Dr Amy Strange
The recent ruling of the European Court of Justice (ECJ) excluding inventions relating to human embryonic stem cells (ES cells) from patentability has sparked a heated debate in the bioscience, ethics and law communities... [Read More]
TV Review: Holby City - Butterflies
31 January 2012 - by Daniel Malynn
In between the epidemic of 'will they, won't they?' relationships spreading throughout Holby City, the show dealt with the genetic disorder epidermolysis bullosa (EB)... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX